Non-Small Cell Lung Cancer Excellence Forum

Non-Small Cell Lung Cancer

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

New Innovations in Screening for NSCLC

11/24/2019

James L. Mulshine, MD, discusses novel techniques in the detection of early-stage NSCLC.

James L. Mulshine, MD, discusses...

11/24/2019

Oncology

Videos

Immunotherapy With or Without Chemo for the First-Line Treatment of NSCLC

11/23/2019

Martin J. Edelman, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses the use of immunotherapy with or without chemo in the first-line treatment of NSCLC.

Martin J. Edelman, MD, Fox Chase...

11/23/2019

Oncology

Videos

Managing Resistance to Third-Generation TKIs in NSCLC

11/22/2019

Lyudmila Bazhenova, MD, talks about understanding, preventing, and delaying EGFR-resistance in the era of osimertinib therapy.

Lyudmila Bazhenova, MD, talks...

11/22/2019

Oncology

Videos

Exploring the Use of Entrectinib in NSCLC

11/08/2019

Stephen Liu, MD, discusses takeaway points from a Product Theater for entrectinib held at the 2019 Perspectives in Thoracic Oncology.

Stephen Liu, MD, discusses...

11/08/2019

Oncology

Interview

Approaches in Radiation for Locally Advanced NSCLC

10/15/2019

Abigail Berman, MD, MSCE, discusses radiation therapy approaches for locally advanced NSCLC.

Abigail Berman, MD, MSCE,...

10/15/2019

Oncology

Interview

First Trial Combining Immunotherapy and LAT for Oligometastatic NSCLC Yields Intriguing Results

08/18/2019

Joshua Bauml, MD, discusses the significance of a trial evaluating the use of pembrolizumab after LAT in patients with oligometastatic NSCLC.

Joshua Bauml, MD, discusses the...

08/18/2019

Oncology

Interview

Hurricanes Tied to Poorer Outcomes in Patients With NSCLC Receiving Radiotherapy

07/30/2019

Leticia M. Nogueira, PhD, MPH, discusses the link between declaration of a hurricane during radiotherapy for NSCLC and worse overall survival.

Leticia M. Nogueira, PhD, MPH,...

07/30/2019

Oncology

Videos

Abigail Berman, MD, Discusses the Role of Proton Therapy in NSCLC

10/31/2018

In this 3-part video series, Dr Berman provides and overview of the debate on photon versus proton radiotherapy for NSCLC and discusses the current treatment landscape for patients with this disease.

In this 3-part video series, Dr...

10/31/2018

Oncology

Videos

Definitive Chemoradiotherapy Promising for Patients With Advanced NSCLC

10/29/2018

Martin Edelman, MD, explains the role of definitive chemoradiotherapy in the treatment of patients with stage III NSCLC.

Martin Edelman, MD, explains the...

10/29/2018

Oncology

Videos

Recent Progress in the Treatment of NSCLC

10/29/2018

Martin Edelman, MD, discusses how treatment for NSCLC has changed in recent years.

Martin Edelman, MD, discusses...

10/29/2018

Oncology

Recent News

FDA Approval

FDA Approves Neoadjuvant/Adjuvant Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer

10/03/2024

Stephanie Holland ;

Based on results from the CHECKMATE-77T trial, the FDA has approved nivolumab plus platinum-doublet chemotherapy followed by surgical resection and single-agent nivolumab for patients with non-small cell lung cancer with no known EGFR...

Based on results from the...

10/03/2024

Oncology

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology

News

Ipilimumab After PD-1 Inhibition Failure Among Patients With Metastatic Melanoma

11/05/2024

Allison Casey ;

A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.

A single-center real-world study...

11/05/2024

Oncology